Abstract
Objective: Analyze ECV results when propofol is used for sedation.
Design: Longitudinal prospective analysis Setting: 1st of January of
2018 and 31st of December of 2020. Population: Pregnant women with
non-cephalic presentation and no contraindication for vaginal delivery.
Methods: Longitudinal prospective analysis of ECV performed in a
tertiary hospital between the Just before the procedure, 0.2 mg/min of
ritodrine was intravenously administered for 30 minutes. Sedation or
neuraxial anesthesia was performed before the ECV. Main Outcome
Measures: ECV success rate, Hypotension during procedure, ECV
complication rate, cesarean section 24 h after ECV. Results: 242
pregnant women underwent ECV. All data were available for analysis just
in 153 cases. ECV success rate was 66.9%. Sedation was performed in
88.8% and neuraxial anesthesia was carried out in 11.2%. For the
sedation group, propofol was used in 96.3%. Emergency cesarean section
rate during the following 24 hours of ECV was 6.7%. No difference in
the emergent cesarean section during the 24 hours following the ECV rate
when sedation or neuraxial anesthesia were performed (p=0.53).
Conclusions: ECV is a safe and effective procedure. Sedation with
propofol is useful for analgesia in ECV. Funding: The authors received
no financial support for the research, authorship, and/or publication of
this article.